Table 3. MicroRNAs validated on validation set 1 (N = 28) and their correlation with TTP (weeks).

MiRNA	Patients (N = 28)	Median TTP (weeks)	Log-Rank P	Adjusted HR	95% CI	P
MiR-31-3p
Low ≤ 0.0155	21	49	< 0.0001	35.051	6.887 to 178.412	<0.001
High > 0.0155	7	16
MiR-31-5p
Low ≤ 0.1378	19	49	0.001	7.369	2.242 to 24.219	<0.001
High > 0.1378	9	16
MiR-378a-5p
Low ≤ 0.0734	15	22	0.1406	0.553	0.251 to 1.216
High > 0.0734	13	49
MiR-595
Low ≤ 0.0142	8	29.5	0.8797	0.935	0.393 to 2.225
High > 0.0142	20	31
MiR-192
Low ≤ 4.7538	18	31	0.6333	1.290	0.369 to 1.834
High > 4.7538	10	40
MiR-455
Low ≤ 0.0753	20	37.5	0.5370	1.348	0.522 to 3.483
High > 0.0753	8	19.5
MiR-30a-3p
Low ≤ 0.065	16	37.5	0.6047	1.238	0.552 to 2.777
High > 0.065	12	22
MiR-636*
MiR-32*

^*Ct values of miR-636 and miR-32 were higher than 35 and considered negative.